KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Change in Account Payables (2018 - 2025)

Historic Change in Account Payables for Astrana Health (ASTH) over the last 8 years, with Q1 2025 value amounting to -$3.4 million.

  • Astrana Health's Change in Account Payables fell 614107.14% to -$3.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$3.0 million, marking a year-over-year decrease of 14953.51%. This contributed to the annual value of $487000.0 for FY2024, which is 24847.56% up from last year.
  • Latest data reveals that Astrana Health reported Change in Account Payables of -$3.4 million as of Q1 2025, which was down 614107.14% from $2.2 million recorded in Q4 2024.
  • In the past 5 years, Astrana Health's Change in Account Payables registered a high of $2.2 million during Q2 2021, and its lowest value of -$4.2 million during Q1 2022.
  • Its 5-year average for Change in Account Payables is -$282470.6, with a median of -$235000.0 in 2022.
  • In the last 5 years, Astrana Health's Change in Account Payables soared by 144236.11% in 2021 and then tumbled by 614107.14% in 2025.
  • Astrana Health's Change in Account Payables (Quarter) stood at $1.7 million in 2021, then decreased by 8.67% to $1.6 million in 2022, then decreased by 5.07% to $1.5 million in 2023, then soared by 47.5% to $2.2 million in 2024, then crashed by 254.97% to -$3.4 million in 2025.
  • Its last three reported values are -$3.4 million in Q1 2025, $2.2 million for Q4 2024, and -$1.3 million during Q3 2024.